Literature DB >> 26193000

Chitosan layered gold nanorods as synergistic therapeutics for photothermal ablation and gene silencing in triple-negative breast cancer.

Zhizhou Yang1, Tengfei Liu2, Yan Xie3, Zhaorui Sun1, Hongmei Liu1, Jinfeng Lin1, Changjing Liu1, Zong-Wan Mao4, Shinan Nie5.   

Abstract

Small interfering RNAs (siRNAs) are extensively studied due to their promising potential as therapeutic agents for a wide variety of diseases, including cancer. However, efficient delivery of siRNAs to target cells and tissues is problematic due to a lack of suitable delivery vehicles. In this work, we developed a layer-by-layer assembled chitosan-gold nanorods (Chit-Au NRs) siRNA delivery system to overcome biological barriers upon systemic injection. This platform was able to protect siRNAs form degradation upon exposure to ribonuclease (RNase) or serum. Confocal and intravital microscopy reveals that Chit-Au NRs/siRNAs are successfully delivered into target cells and tissue, and can efficiently escape from endosomal/lysosomal structures. Furthermore, Chit-Au NRs/siRNA were found to accumulate in high levels in tumor tissue. The delivery system was able to inhibit the oncogene expression (pyruvate kinase isozymeM2, PKM2) in MDA-MB-231 triple negative breast cancer cells, resulting in suppression of cell proliferation and migration. Moreover, the anticancer efficacy was further enhanced through NR-mediated photothermal ablation. In conclusion, the synergistic therapeutic properties of Chit-Au NRs/siRNA enable effective suppression of cancer growth. STATEMENT OF SIGNIFICANCE: Small interfering RNA (siRNA) therapy has promising therapeutic applications, since the expression of any protein can be suppressed. However the successful implementation of siRNA has been challenging, due to rapid degradation, poor intracellular uptake and insufficient endosomal escape. Here, we have developed a gold nanorod/chitosan-based delivery vehicle for siRNA therapy. This platform successfully overcomes the afore-mentioned challenges and can simultaneously be used for photothermal therapy, due to the optical properties of gold nanorods. We show that the anticancer activity is dramatically improved by combining thermal therapy with gene silencing. Furthermore, the Au NRs carrier shows high accumulation in tumor tissue and high transfection efficiency. This manuscript has been reviewed and approved by all co-authors. The research has not been disclosed or published and is not under consideration for publication elsewhere. We would appreciate if the manuscript could be reviewed and considered for publication in Acta BIOMATERIALIA.
Copyright © 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Chitosan; Gold nanorods; Photothermal ablation; Small interfering RNA

Mesh:

Substances:

Year:  2015        PMID: 26193000     DOI: 10.1016/j.actbio.2015.07.026

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  10 in total

1.  IR820-loaded PLGA nanoparticles for photothermal therapy of triple-negative breast cancer.

Authors:  Danielle M Valcourt; Megan N Dang; Emily S Day
Journal:  J Biomed Mater Res A       Date:  2019-04-09       Impact factor: 4.396

Review 2.  Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC).

Authors:  Aiswarya Chaudhuri; Dulla Naveen Kumar; Deepa Dehari; Sanjay Singh; Pradeep Kumar; Pradeep Kumar Bolla; Dinesh Kumar; Ashish Kumar Agrawal
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-27

Review 3.  Functionalized gold nanostructures: promising gene delivery vehicles in cancer treatment.

Authors:  Sanjay Kumar; Anchita Diwan; Parinita Singh; Shikha Gulati; Devanshu Choudhary; Ayush Mongia; Shefali Shukla; Akanksha Gupta
Journal:  RSC Adv       Date:  2019-08-01       Impact factor: 4.036

Review 4.  Trigger-Responsive Gene Transporters for Anticancer Therapy.

Authors:  Santhosh Kalash Rajendrakumar; Saji Uthaman; Chong Su Cho; In-Kyu Park
Journal:  Nanomaterials (Basel)       Date:  2017-05-26       Impact factor: 5.076

Review 5.  Multicomponent, Tumor-Homing Chitosan Nanoparticles for Cancer Imaging and Therapy.

Authors:  Jaehong Key; Kyeongsoon Park
Journal:  Int J Mol Sci       Date:  2017-03-08       Impact factor: 5.923

6.  Effective in Vitro Photokilling by Cell-Adhesive Gold Nanorods.

Authors:  Álvaro Artiga; Sonia García-Embid; Laura De Matteis; Scott G Mitchell; Jesús M de la Fuente
Journal:  Front Chem       Date:  2018-06-22       Impact factor: 5.221

7.  Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.

Authors:  Beibei Ma; Jie Sheng; Ping Wang; Zhongying Jiang; Entomack Borrathybay
Journal:  Int J Nanomedicine       Date:  2019-06-20

Review 8.  Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics.

Authors:  Jianliang Shen; Wei Zhang; Ruogu Qi; Zong-Wan Mao; Haifa Shen
Journal:  Chem Soc Rev       Date:  2018-02-08       Impact factor: 60.615

Review 9.  Recent advances in siRNA delivery mediated by lipid-based nanoparticles.

Authors:  Sei Yonezawa; Hiroyuki Koide; Tomohiro Asai
Journal:  Adv Drug Deliv Rev       Date:  2020-08-06       Impact factor: 15.470

Review 10.  Gold Nanorods for Drug and Gene Delivery: An Overview of Recent Advancements.

Authors:  Atieh Jahangiri-Manesh; Marziyeh Mousazadeh; Shirinsadat Taji; Abbas Bahmani; Atefeh Zarepour; Ali Zarrabi; Esmaeel Sharifi; Mostafa Azimzadeh
Journal:  Pharmaceutics       Date:  2022-03-17       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.